| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pbf-999 | adenosine a2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Huntington Disease[MeSHID:D006816] |
0.61 | phase 1 | antagonist |
| pbf-999 | phosphodiesterase 10a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Huntington Disease[MeSHID:D006816] |
6.37 | phase 1 | inhibitor |
| click here to return to the previous page | ||||||||